AYLo study–elevated relapse risk and dysregulated proinflammatory signalling in giant cell arteritis patients with mosaic loss of the Y chromosome
Annals of the Rheumatic Diseases · 2025-11 · 84 (11) · 1900-1908
DOI: 10.1016/j.ard.2025.06.2133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2025-11. Verfasst von Simon M Petzinna und 12 weiteren Autor:innen. Beteiligte Einrichtung: Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital of Bonn, Bonn, Germany. Electronic address: Simon_…. Hauptthemen laut MEDLINE: Giant Cell Arteritis, Chromosomes, Human, Y. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Multiple System Atrophy Coalition.
Abstract (Originalsprache)
OBJECTIVES: To assess the prevalence of mosaic loss of the Y chromosome (mLOY) in giant cell arteritis (GCA) and its impact on disease activity. METHODS: Patients diagnosed with GCA were prospectively recruited, and their leukocyte mLOY burden was analysed. The optimal mLOY threshold for predicting relapse was determined using the receiver operating characteristic curve and Youden index. Relapse-free survival was assessed using Kaplan-Meier analysis with the log-rank test. Levels of selected proinflammatory cytokines were quantified using a multiplex array. RESULTS: A total of 74 GCA patients were enrolled (mean, 76.0 years; SD, 10.7). At inclusion, 25.7% (19/74) of patients exhibited active disease. Relapses occurred in 23.0% of patients. The median mLOY burden was 17.8% (SD, 23.7%). An optimal threshold of 10.2% was identified for predicting relapse. Patients exceeding this cutoff had a significantly higher relapse risk (P 10.2% as an independent predictor of relapse (hazard ratio, 17.4; 95% CI, 3.5-86.0; P = .003). In multiplex analysis, mLOY was positively associated with interleukin (IL)-6 (P = .045; r = 0.24) across the cohort, with elevated IL-6 levels in remission patients with mLOY >10.2% (P = .010). In patients undergoing IL-6 receptor inhibitor treatment and in remission, mLOY was significantly positively associated with IL-6 (P = .002; r = 0.54) and IL-17A (P = .026; r = 0.40). CONCLUSIONS: This study is the first to identify mLOY as a strong, independent predictor of relapse risk and to link mLOY with modulated proinflammatory signalling in GCA. Our findings suggest mLOY as a prognostic biomarker and underscore its possible role in the pathophysiology of GCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital of Bonn, Bonn, Germany. Electronic address: Simon_Michael.Petzinna@ukbonn.de.
- Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital of Bonn, Bonn, Germany.
- Institute for Clinical Chemistry and Clinical Pharmacology, University Hospital of Bonn, Bonn, Germany.
- Department of Cardiology, University Hospital of Bonn, Bonn, Germany.
Förderung
- Multiple System Atrophy Coalition
Zitieren
APA
Petzinna, S. M., Kirch, S. M., Adamson, M. S., Xi, Bauer, C. J., Kreis, L., Gheitasi, R., Karakostas, P., Behrendt, R., Nickenig, G., Zimmer, S., Jamin, R. N., & Schäfer, V. S. (2025). AYLo study–elevated relapse risk and dysregulated proinflammatory signalling in giant cell arteritis patients with mosaic loss of the Y chromosome. Annals of the Rheumatic Diseases, 84(11), 1900-1908. https://doi.org/10.1016/j.ard.2025.06.2133
Vancouver
Petzinna SM, Kirch SM, Adamson MS, Xi, Bauer CJ, Kreis L, et al. AYLo study–elevated relapse risk and dysregulated proinflammatory signalling in giant cell arteritis patients with mosaic loss of the Y chromosome. Annals of the Rheumatic Diseases. 2025;84(11):1900-1908. doi:10.1016/j.ard.2025.06.2133
BibTeX
@article{Petzinna2025,
author = {Petzinna, Simon M and Kirch, Sophie-Marie and Adamson, Maike S and Xi, De and Bauer, Claus-Jürgen and Kreis, Lena and Gheitasi, Reza and Karakostas, Pantelis and Behrendt, Rayk and Nickenig, Georg and Zimmer, Sebastian and Jamin, Raul N and Schäfer, Valentin S},
title = {AYLo study–elevated relapse risk and dysregulated proinflammatory signalling in giant cell arteritis patients with mosaic loss of the Y chromosome},
journal = {Annals of the Rheumatic Diseases},
year = {2025},
volume = {84},
number = {11},
pages = {1900--1908},
doi = {10.1016/j.ard.2025.06.2133}
}
EUVIMED